US stocks were higher at the close with the Dow Jones up more than 400 points on Wednesday.
The Dow was up 1.51% to 29,575.89, while the NASDAQ was up 1.52% to 10,994.11. The S&P 500 was also up 1.56% to 3,704.06.
Also Check This: These Analysts Boost PT on Biogen
Leading and lagging sectors
Energy stocks rose 3.7% on Wednesday.
In Wednesday trading, shares of information technology rose just 0.4%.
top heading
US crude inventories fell 0.215 million barrels in the week ended September 23 versus market estimates of a 0.443 million barrel increase, the Energy Information Administration said.
Stock trading UP
PepGen Inc. PEPG Shares rose 85% to $9.62 after the company announced results of its phase 1 study in healthy volunteers of PGN-EDO51 for Duchenne muscular dystrophy. The study met its primary endpoint.
shares of bioAffinity Technologies, Inc. BIAF got a boost, rising 37% to $2.90 after the company announced it had received an additional $7.7 million from the exercise of warrants.
Acumen Pharmaceuticals, Inc. SUBSCRIPTION Shares were also higher, gaining 105% to $9.64 after Biogen and Eisai announced their Phase 3 Clarity trial of lecanemab met its primary endpoint.
Stocks are trading down
Mind Medicine (MindMed) Inc. MNMD Shares fell 50% to $3.06 after the company priced an offering of 7.05 million shares with common shares and warrants at $4.25 per share plus warrants.
shares of nano labs ltd N / A fell 33% to $2.1225 after the company priced a public offering of approximately 2.08 million ADS at $2.40 per ADS.
PhaseBio Pharmaceuticals, Inc. PHAS was down 65% to $0.2660 after the company said it had received notice that its partner SFJ Pharmaceuticals Group had elected to transfer bentracimab rights to SFJ as PhaseBio announced its going -Could not resolve concern condition.
Also check out: Amazon at $170?
raw materials
On commodities news, oil traded up 4.7% to $82.22, while gold traded up 2% to $1,668.80.
Silver was up 3.1% on…
